Literature DB >> 10698681

Alpha-synuclein overexpression promotes aggregation of mutant huntingtin.

R A Furlong1, Y Narain, J Rankin, A Wyttenbach, D C Rubinsztein.   

Abstract

Protein aggregates are a neuropathological feature of Huntington's disease and Parkinson's disease. Mutant huntingtin exon 1 with 72 CAG repeats fused to enhanced green fluorescent protein (EGFP) forms hyperfluorescent inclusions in PC12 cells. Inclusion formation is enhanced in cells co-transfected with EGFP-huntingtin-(CAG)(72) and alpha-synuclein, a major component of Parkinson's disease aggregates. However, alpha-synuclein does not form aggregates by itself, nor does it appear in huntingtin inclusions in vitro.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10698681      PMCID: PMC1220887     

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  30 in total

Review 1.  Alpha synuclein in neurodegenerative disorders: murderer or accomplice?

Authors:  E Mezey; A Dehejia; G Harta; M I Papp; M H Polymeropoulos; M J Brownstein
Journal:  Nat Med       Date:  1998-07       Impact factor: 53.440

2.  Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease.

Authors:  R Krüger; W Kuhn; T Müller; D Woitalla; M Graeber; S Kösel; H Przuntek; J T Epplen; L Schöls; O Riess
Journal:  Nat Genet       Date:  1998-02       Impact factor: 38.330

3.  Suppression of aggregate formation and apoptosis by transglutaminase inhibitors in cells expressing truncated DRPLA protein with an expanded polyglutamine stretch.

Authors:  S Igarashi; R Koide; T Shimohata; M Yamada; Y Hayashi; H Takano; H Date; M Oyake; T Sato; A Sato; S Egawa; T Ikeuchi; H Tanaka; R Nakano; K Tanaka; I Hozumi; T Inuzuka; H Takahashi; S Tsuji
Journal:  Nat Genet       Date:  1998-02       Impact factor: 38.330

4.  Length of huntingtin and its polyglutamine tract influences localization and frequency of intracellular aggregates.

Authors:  D Martindale; A Hackam; A Wieczorek; L Ellerby; C Wellington; K McCutcheon; R Singaraja; P Kazemi-Esfarjani; R Devon; S U Kim; D E Bredesen; F Tufaro; M R Hayden
Journal:  Nat Genet       Date:  1998-02       Impact factor: 38.330

5.  Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain.

Authors:  M DiFiglia; E Sapp; K O Chase; S W Davies; G P Bates; J P Vonsattel; N Aronin
Journal:  Science       Date:  1997-09-26       Impact factor: 47.728

6.  A molecular investigation of true dominance in Huntington's disease.

Authors:  Y Narain; A Wyttenbach; J Rankin; R A Furlong; D C Rubinsztein
Journal:  J Med Genet       Date:  1999-10       Impact factor: 6.318

7.  Regulation of phospholipase D2: selective inhibition of mammalian phospholipase D isoenzymes by alpha- and beta-synucleins.

Authors:  J M Jenco; A Rawlingson; B Daniels; A J Morris
Journal:  Biochemistry       Date:  1998-04-07       Impact factor: 3.162

8.  Truncated N-terminal fragments of huntingtin with expanded glutamine repeats form nuclear and cytoplasmic aggregates in cell culture.

Authors:  J K Cooper; G Schilling; M F Peters; W J Herring; A H Sharp; Z Kaminsky; J Masone; F A Khan; M Delanoy; D R Borchelt; V L Dawson; T M Dawson; C A Ross
Journal:  Hum Mol Genet       Date:  1998-05       Impact factor: 6.150

9.  Spinocerebellar ataxia type 7 (SCA7): a neurodegenerative disorder with neuronal intranuclear inclusions.

Authors:  M Holmberg; C Duyckaerts; A Dürr; G Cancel; I Gourfinkel-An; P Damier; B Faucheux; Y Trottier; E C Hirsch; Y Agid; A Brice
Journal:  Hum Mol Genet       Date:  1998-05       Impact factor: 6.150

10.  Chaperone suppression of aggregation and altered subcellular proteasome localization imply protein misfolding in SCA1.

Authors:  C J Cummings; M A Mancini; B Antalffy; D B DeFranco; H T Orr; H Y Zoghbi
Journal:  Nat Genet       Date:  1998-06       Impact factor: 38.330

View more
  31 in total

1.  Expression of A53T mutant but not wild-type alpha-synuclein in PC12 cells induces alterations of the ubiquitin-dependent degradation system, loss of dopamine release, and autophagic cell death.

Authors:  L Stefanis; K E Larsen; H J Rideout; D Sulzer; L A Greene
Journal:  J Neurosci       Date:  2001-12-15       Impact factor: 6.167

2.  Phosphorylation at serine 31 targets tyrosine hydroxylase to vesicles for transport along microtubules.

Authors:  Ana Jorge-Finnigan; Rune Kleppe; Kunwar Jung-Kc; Ming Ying; Michael Marie; Ivan Rios-Mondragon; Michael F Salvatore; Jaakko Saraste; Aurora Martinez
Journal:  J Biol Chem       Date:  2017-06-21       Impact factor: 5.157

3.  Alpha-synuclein delays mitophagy and targeting Miro rescues neuron loss in Parkinson's models.

Authors:  Atossa Shaltouki; Chung-Han Hsieh; Min Joo Kim; Xinnan Wang
Journal:  Acta Neuropathol       Date:  2018-06-09       Impact factor: 17.088

4.  α-Synuclein forms non-selective cation channels and stimulates ATP-sensitive potassium channels in hippocampal neurons.

Authors:  Sergej L Mironov
Journal:  J Physiol       Date:  2014-11-13       Impact factor: 5.182

5.  Bacterial and yeast chaperones reduce both aggregate formation and cell death in mammalian cell models of Huntington's disease.

Authors:  J Carmichael; J Chatellier; A Woolfson; C Milstein; A R Fersht; D C Rubinsztein
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-15       Impact factor: 11.205

6.  Manganese promotes the aggregation and prion-like cell-to-cell exosomal transmission of α-synuclein.

Authors:  Dilshan S Harischandra; Dharmin Rokad; Matthew L Neal; Shivani Ghaisas; Sireesha Manne; Souvarish Sarkar; Nikhil Panicker; Gary Zenitsky; Huajun Jin; Mechelle Lewis; Xuemei Huang; Vellareddy Anantharam; Arthi Kanthasamy; Anumantha G Kanthasamy
Journal:  Sci Signal       Date:  2019-03-12       Impact factor: 8.192

7.  Parkinson Disease-linked Vps35 R524W Mutation Impairs the Endosomal Association of Retromer and Induces α-Synuclein Aggregation.

Authors:  Jordan Follett; Andrea Bugarcic; Zhe Yang; Nicholas Ariotti; Suzanne J Norwood; Brett M Collins; Robert G Parton; Rohan D Teasdale
Journal:  J Biol Chem       Date:  2016-07-06       Impact factor: 5.157

8.  α-Synuclein levels modulate Huntington's disease in mice.

Authors:  Silvia Corrochano; Maurizio Renna; Sarah Carter; Nichola Chrobot; Rose Kent; Michelle Stewart; Jason Cooper; Steve D M Brown; David C Rubinsztein; Abraham Acevedo-Arozena
Journal:  Hum Mol Genet       Date:  2011-10-18       Impact factor: 6.150

Review 9.  An in vitro perspective on the molecular mechanisms underlying mutant huntingtin protein toxicity.

Authors:  G Cisbani; F Cicchetti
Journal:  Cell Death Dis       Date:  2012-08-30       Impact factor: 8.469

Review 10.  Huntington's Disease: Mechanisms of Pathogenesis and Therapeutic Strategies.

Authors:  Maria Jimenez-Sanchez; Floriana Licitra; Benjamin R Underwood; David C Rubinsztein
Journal:  Cold Spring Harb Perspect Med       Date:  2017-07-05       Impact factor: 6.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.